Pharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist
Pharmaceutical Executive Daily: Mirum Pharmaceuticals Acquires Bluejay Therapeutics
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk



Pharmaceutical Executive